Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.
2.

Health system strengthening-Reflections on its meaning, assessment, and our state of knowledge.

Witter S, Palmer N, Balabanova D, Mounier-Jack S, Martineau T, Klicpera A, Jensen C, Pugliese-Garcia M, Gilson L.

Int J Health Plann Manage. 2019 Aug 6. doi: 10.1002/hpm.2882. [Epub ahead of print]

PMID:
31386232
3.

Optimising informed consent in school-based adolescent vaccination programmes in England: A multiple methods analysis.

Chantler T, Letley L, Paterson P, Yarwood J, Saliba V, Mounier-Jack S.

Vaccine. 2019 Aug 23;37(36):5218-5224. doi: 10.1016/j.vaccine.2019.07.061. Epub 2019 Jul 24.

4.
5.

Strengthening HPV vaccination delivery: findings from a qualitative service evaluation of the adolescent girls' HPV vaccination programme in England.

Paterson P, Mounier-Jack S, Saliba V, Yarwood J, White J, Ramsay M, Chantler T.

J Public Health (Oxf). 2019 Jun 20. pii: fdz061. doi: 10.1093/pubmed/fdz061. [Epub ahead of print]

6.

What is the cost of delivering routine vaccinations at GP practices in England? A comparative time-driven activity-based costing analysis.

Crocker-Buque T, Mohan K, Ramsay M, Edelstein M, Mounier-Jack S.

Hum Vaccin Immunother. 2019;15(12):3016-3023. doi: 10.1080/21645515.2019.1619403. Epub 2019 Jun 14.

7.

Value and effectiveness of National Immunization Technical Advisory Groups in low- and middle-income countries: a qualitative study of global and national perspectives.

Bell S, Blanchard L, Walls H, Mounier-Jack S, Howard N.

Health Policy Plan. 2019 May 1;34(4):271-281. doi: 10.1093/heapol/czz027.

8.

Is partnership the answer? Delivering the national immunisation programme in the new English health system: a mixed methods study.

Chantler T, Bell S, Saliba V, Heffernan C, Raj T, Ramsay M, Mounier-Jack S.

BMC Public Health. 2019 Jan 17;19(1):83. doi: 10.1186/s12889-019-6400-6.

9.
10.

Vaccination in England: a review of why business as usual is not enough to maintain coverage.

Crocker-Buque T, Mounier-Jack S.

BMC Public Health. 2018 Dec 6;18(1):1351. doi: 10.1186/s12889-018-6228-5.

11.

Vaccine programme stakeholder perspectives on a hypothetical single-dose human papillomavirus (HPV) vaccine schedule in low and middle-income countries.

Gallagher KE, Kelly H, Cocks N, Dixon S, Mounier-Jack S, Howard N, Watson-Jones D.

Papillomavirus Res. 2018 Dec;6:33-40. doi: 10.1016/j.pvr.2018.10.004. Epub 2018 Oct 21.

12.

A process evaluation of how the routine vaccination programme is implemented at GP practices in England.

Crocker-Buque T, Edelstein M, Mounier-Jack S.

Implement Sci. 2018 Oct 22;13(1):132. doi: 10.1186/s13012-018-0824-8.

13.

Performance-based financing versus improving salary payments to workers: insights from the Democratic Republic of Congo.

Maini R, Mounier-Jack S, Borghi J.

BMJ Glob Health. 2018 Sep 25;3(5):e000958. doi: 10.1136/bmjgh-2018-000958. eCollection 2018. No abstract available.

14.

Perspectives of vaccinators on the factors affecting uptake of meningococcal ACWY vaccine amongst school leavers in London.

Seok J, Heffernan C, Mounier-Jack S, Chantler T.

Public Health. 2018 Nov;164:128-133. doi: 10.1016/j.puhe.2018.08.002. Epub 2018 Oct 3.

15.
16.

Who is responsible for the vaccination of migrants in Europe?

Hargreaves S, Nellums LB, Ramsay M, Saliba V, Majeed A, Mounier-Jack S, Friedland JS.

Lancet. 2018 May 5;391(10132):1752-1754. doi: 10.1016/S0140-6736(18)30846-8. No abstract available.

17.

How to and how not to develop a theory of change to evaluate a complex intervention: reflections on an experience in the Democratic Republic of Congo.

Maini R, Mounier-Jack S, Borghi J.

BMJ Glob Health. 2018 Jan 3;3(1):e000617. doi: 10.1136/bmjgh-2017-000617. eCollection 2018. Review.

18.

The need for sustainability and alignment of future support for National Immunization Technical Advisory Groups (NITAGs) in low and middle-income countries.

Howard N, Bell S, Walls H, Blanchard L, Brenzel L, Jit M, Mounier-Jack S.

Hum Vaccin Immunother. 2018 Jun 3;14(6):1539-1541. doi: 10.1080/21645515.2018.1444321. Epub 2018 Mar 26.

19.

Integrated care: learning between high-income, and low- and middle-income country health systems.

Mounier-Jack S, Mayhew SH, Mays N.

Health Policy Plan. 2017 Nov 1;32(suppl_4):iv6-iv12. doi: 10.1093/heapol/czx039.

20.

Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016.

Gallagher KE, Howard N, Kabakama S, Mounier-Jack S, Burchett HED, LaMontagne DS, Watson-Jones D.

Papillomavirus Res. 2017 Dec;4:72-78. doi: 10.1016/j.pvr.2017.09.001. Epub 2017 Oct 3.

21.

What works for human papillomavirus vaccine introduction in low and middle-income countries?

Howard N, Gallagher KE, Mounier-Jack S, Burchett HED, Kabakama S, LaMontagne DS, Watson-Jones D.

Papillomavirus Res. 2017 Dec;4:22-25. doi: 10.1016/j.pvr.2017.06.003. Epub 2017 Jun 8. Review.

22.

The need for speed: the peer-review process and what are we doing about it?

Epstein D, Wiseman V, Salaria N, Mounier-Jack S.

Health Policy Plan. 2017 Dec 1;32(10):1345-1346. doi: 10.1093/heapol/czx129. No abstract available.

23.

Immunization, urbanization and slums - a systematic review of factors and interventions.

Crocker-Buque T, Mindra G, Duncan R, Mounier-Jack S.

BMC Public Health. 2017 Jun 8;17(1):556. doi: 10.1186/s12889-017-4473-7. Review.

24.

Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries.

Gallagher KE, Howard N, Kabakama S, Mounier-Jack S, Griffiths UK, Feletto M, Burchett HED, LaMontagne DS, Watson-Jones D.

PLoS One. 2017 Jun 2;12(6):e0177773. doi: 10.1371/journal.pone.0177773. eCollection 2017.

25.

Comments on "Monitoring vaccination coverage: Defining the role of surveys".

Pond R, Mounier-Jack S.

Vaccine. 2016 Dec 7;34(50):6111. doi: 10.1016/j.vaccine.2016.09.066. No abstract available.

PMID:
27899196
26.

The International Finance Facility for Immunisation: stakeholders' perspectives.

Crocker-Buque T, Mounier-Jack S.

Bull World Health Organ. 2016 Sep 1;94(9):687-693. Epub 2016 Jun 28. Erratum in: Bull World Health Organ. ;94(10 ):784.

27.

"It's a complex mesh"- how large-scale health system reorganisation affected the delivery of the immunisation programme in England: a qualitative study.

Chantler T, Lwembe S, Saliba V, Raj T, Mays N, Ramsay M, Mounier-Jack S.

BMC Health Serv Res. 2016 Sep 15;16:489. doi: 10.1186/s12913-016-1711-0.

28.

Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countries.

Kabakama S, Gallagher KE, Howard N, Mounier-Jack S, Burchett HE, Griffiths UK, Feletto M, LaMontagne DS, Watson-Jones D.

BMC Public Health. 2016 Aug 19;16(1):834. doi: 10.1186/s12889-016-3517-8.

29.

Interventions to reduce inequalities in vaccine uptake in children and adolescents aged <19 years: a systematic review.

Crocker-Buque T, Edelstein M, Mounier-Jack S.

J Epidemiol Community Health. 2017 Jan;71(1):87-97. doi: 10.1136/jech-2016-207572. Epub 2016 Aug 17. Review.

30.

One year of campaigns in Cameroon: effects on routine health services.

Mounier-Jack S, Edengue JM, Lagarde M, Baonga SF, Ongolo-Zogo P.

Health Policy Plan. 2016 Nov;31(9):1225-31. doi: 10.1093/heapol/czw054. Epub 2016 May 11.

31.

The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries.

Howard N, Mounier-Jack S, Gallagher KE, Kabakama S, Griffiths UK, Feletto M, LaMontagne DS, Burchett HE, Watson-Jones D.

Hum Vaccin Immunother. 2016 Sep;12(9):2475-7. doi: 10.1080/21645515.2016.1178433. Epub 2016 May 9.

32.

New pneumococcal conjugate vaccine introductions in four sub-Saharan African countries: a cross-country analysis of health systems' impacts.

Torres-Rueda S, Burchett HE, Griffiths UK, Ongolo-Zogo P, Edengue JM, Kitaw Y, Molla M, Gelmon L, Onyango-Ouma W, Konate M, Mounier-Jack S.

Afr Health Sci. 2015 Sep;15(3):868-77. doi: 10.4314/ahs.v15i3.22.

33.

Factors influencing completion of multi-dose vaccine schedules in adolescents: a systematic review.

Gallagher KE, Kadokura E, Eckert LO, Miyake S, Mounier-Jack S, Aldea M, Ross DA, Watson-Jones D.

BMC Public Health. 2016 Feb 19;16:172. doi: 10.1186/s12889-016-2845-z. Review.

34.

HPV vaccine introduction in Rwanda: Impacts on the broader health system.

Torres-Rueda S, Rulisa S, Burchett HE, Mivumbi NV, Mounier-Jack S.

Sex Reprod Healthc. 2016 Mar;7:46-51. doi: 10.1016/j.srhc.2015.11.006. Epub 2015 Nov 26.

35.

Meningococcal vaccine introduction in Mali through mass campaigns and its impact on the health system.

Mounier-Jack S, Burchett HE, Griffiths UK, Konate M, Diarra KS.

Glob Health Sci Pract. 2014 Jan 15;2(1):117-29. doi: 10.9745/GHSP-D-13-00130. eCollection 2014 Feb.

36.

The impact of introducing new vaccines on the health system: case studies from six low- and middle-income countries.

Burchett HE, Mounier-Jack S, Torres-Rueda S, Griffiths UK, Ongolo-Zogo P, Rulisa S, Edengue JM, Chavez E, Kitaw Y, Molla M, Konate M, Gelmon L, Onyango-Ouma W, Lagarde M, Mills A.

Vaccine. 2014 Nov 12;32(48):6505-12.

37.

Measuring the health systems impact of disease control programmes: a critical reflection on the WHO building blocks framework.

Mounier-Jack S, Griffiths UK, Closser S, Burchett H, Marchal B.

BMC Public Health. 2014 Mar 25;14:278. doi: 10.1186/1471-2458-14-278.

38.

Assessing the effects of HIV/AIDS and TB disease control programmes on health systems in low- and middle-income countries of Southeast Asia: a semi-systematic review of the literature.

Conseil A, Mounier-Jack S, Rudge JW, Coker R.

Public Health. 2013 Dec;127(12):1063-73. doi: 10.1016/j.puhe.2013.09.013. Epub 2013 Nov 22. Review.

PMID:
24275033
39.

New vaccine introductions: assessing the impact and the opportunities for immunization and health systems strengthening.

Wang SA, Hyde TB, Mounier-Jack S, Brenzel L, Favin M, Gordon WS, Shearer JC, Mantel CF, Arora N, Durrheim D.

Vaccine. 2013 Apr 18;31 Suppl 2:B122-8. doi: 10.1016/j.vaccine.2012.10.116. Review.

40.

The impact of new vaccine introduction on immunization and health systems: a review of the published literature.

Hyde TB, Dentz H, Wang SA, Burchett HE, Mounier-Jack S, Mantel CF; New Vaccine Introduction Impact Published Literature Working Group.

Vaccine. 2012 Oct 5;30(45):6347-58. doi: 10.1016/j.vaccine.2012.08.029. Epub 2012 Aug 29. Review.

41.
42.

New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries.

Burchett HE, Mounier-Jack S, Griffiths UK, Biellik R, Ongolo-Zogo P, Chavez E, Sarma H, Uddin J, Konate M, Kitaw Y, Molla M, Wakasiaka S, Gilson L, Mills A.

Health Policy Plan. 2012 May;27 Suppl 2:ii5-16. doi: 10.1093/heapol/czs035.

PMID:
22513732
43.

National decision-making on adopting new vaccines: a systematic review.

Burchett HE, Mounier-Jack S, Griffiths UK, Mills AJ.

Health Policy Plan. 2012 May;27 Suppl 2:ii62-76. doi: 10.1093/heapol/czr049. Epub 2011 Jul 6. Review.

PMID:
21733989
44.

Impact of measles elimination activities on immunization services and health systems: findings from six countries.

Hanvoravongchai P, Mounier-Jack S, Oliveira Cruz V, Balabanova D, Biellik R, Kitaw Y, Koehlmoos T, Loureiro S, Molla M, Nguyen H, Ongolo-Zogo P, Sadykova U, Sarma H, Teixeira M, Uddin J, Dabbagh A, Griffiths UK.

J Infect Dis. 2011 Jul;204 Suppl 1:S82-9. doi: 10.1093/infdis/jir091.

PMID:
21666218
45.

How can measles eradication strengthen health care systems?

Griffiths UK, Mounier-Jack S, Oliveira-Cruz V, Balabanova D, Hanvoravongchai P, Ongolo P.

J Infect Dis. 2011 Jul;204 Suppl 1:S78-81. doi: 10.1093/infdis/jir090.

PMID:
21666217
46.

Towards a conceptual framework to support one-health research for policy on emerging zoonoses.

Coker R, Rushton J, Mounier-Jack S, Karimuribo E, Lutumba P, Kambarage D, Pfeiffer DU, Stärk K, Rweyemamu M.

Lancet Infect Dis. 2011 Apr;11(4):326-31. doi: 10.1016/S1473-3099(10)70312-1. Epub 2011 Mar 2. Review.

PMID:
21376670
47.

Measles eradication: past is prologue.

Heymann DL, Fine PE, Griffiths UK, Hall AJ, Mounier-Jack S.

Lancet. 2010 Nov 20;376(9754):1719-20. doi: 10.1016/S0140-6736(10)61934-4. No abstract available.

PMID:
21093636
48.

Responding to pandemic influenza in Cambodia and Lao PDR: challenges in moving from strategy to operation.

de Sa J, Mounier-Jack S, Darapheak C, Narann LK, Phetsouvanh R, Chanthakoummane N, Touch S, Phommasack B, Coker R.

Southeast Asian J Trop Med Public Health. 2010 Sep;41(5):1104-15.

PMID:
21073031
49.

Critical interactions between Global Fund-supported programmes and health systems: a case study in Papua New Guinea.

Rudge JW, Phuanakoonon S, Nema KH, Mounier-Jack S, Coker R.

Health Policy Plan. 2010 Nov;25 Suppl 1:i48-52. doi: 10.1093/heapol/czq058.

PMID:
20966110
50.

Critical interactions between Global Fund-supported programmes and health systems: a case study in Indonesia.

Desai M, Rudge JW, Adisasmito W, Mounier-Jack S, Coker R.

Health Policy Plan. 2010 Nov;25 Suppl 1:i43-47. doi: 10.1093/heapol/czq057.

PMID:
20966109

Supplemental Content

Loading ...
Support Center